Dr. Chien-Ping Ko is a renowned expert in synaptic structure, function, formation, and repair at the neuromuscular junction and sensory-motor synapses. He is also an expert in synapse-glia interactions. He has a wealth of experience in preclinical research in ALS and spinal muscular atrophy. His preclinical research was pivotal in the development of Evrysdi, the first oral drug approved for treating SMA in 2020.